![Western Blot: NCOR1 Antibody (7A7A9) [NBP1-28863] - Analysis using NCOR1 mouse mAb against truncated Trx-NCOR1 recombinant protein (1).](http://images.novusbio.com/fullsize/NCOR1-Antibody-7A7A9-Western-Blot-NBP1-28863-img0006.jpg "Western Blot: NCOR1 Antibody (7A7A9) [NBP1-28863] - Analysis using NCOR1 mouse mAb against truncated Trx-NCOR1 recombinant protein (1).")
| Reactivity | HuSpecies Glossary |
| Applications | WB, ELISA, ICC/IF, IHC |
| Clone | 7A7A9 |
| Clonality | Monoclonal |
| Host | Mouse |
| Conjugate | Unconjugated |
| Format | BSA Free |
| Immunogen | Purified recombinant fragment of NCOR1 (aa1-192) expressed in E. Coli. |
| Specificity | Specific for NCOR1. |
| Isotype | IgG1 |
| Clonality | Monoclonal |
| Host | Mouse |
| Gene | NCOR1 |
| Purity | Unpurified |
| Innovator's Reward | Test in a species/application not listed above to receive a full credit towards a future purchase. |
| Dilutions |
|
|
| Application Notes | Use in ICC/IF was reported in scientific literature (PMID: 31661545). |
|
| Publications |
|
| Storage | Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles. |
| Buffer | Ascites |
| Preservative | 0.03% Sodium Azide |
| Purity | Unpurified |
Secondary Antibodies |
Isotype Controls |
Research Areas for NCOR1 Antibody (NBP1-28863)Find related products by research area.
|
|
Muscular Dystrophy Regulation: Ezh2, NCoR-1 Over the years muscular dystrophies have become a popular area of research. These are a group of inherited disorders that involve an increase in muscle weakness over time. These disorders greatly decrease the quality of life and there are no known cur... Read full blog post. |
|
NCOR & EZH2 in Muscular Dystrophy Over the years muscular dystrophies have become a popular area of research. These are a group of inherited disorders that involve an increase in muscle weakness over time. These disorders greatly decrease the quality of life and there are no known cur... Read full blog post. |
The concentration calculator allows you to quickly calculate the volume, mass or concentration of your vial. Simply enter your mass, volume, or concentration values for your reagent and the calculator will determine the rest.
![Immunohistochemistry: NCOR1 Antibody (7A7A9) [NBP1-28863] - Analysis of NCOR1 (brown signal) in glioma clinical samples. Nucleus (blue signal) was stained with hematoxylin. Study displayed downregulation of NCOR1 in GBM centers. Image collected and cropped by CiteAb from the following publication (//pubmed.ncbi.nlm.nih.gov/33761934/) licensed under a CC-BY license.](http://images.novusbio.com/fullsize/NCOR1-Antibody-7A7A9-Immunohistochemistry-NBP1-28863-img0007.jpg "Immunohistochemistry: NCOR1 Antibody (7A7A9) [NBP1-28863] - Analysis of NCOR1 (brown signal) in glioma clinical samples. Nucleus (blue signal) was stained with hematoxylin. Study displayed downregulation of NCOR1 in GBM centers. Image collected and cropped by CiteAb from the following publication (//pubmed.ncbi.nlm.nih.gov/33761934/) licensed under a CC-BY license.")
![Immunohistochemistry-Paraffin: NCOR1 Antibody (7A7A9) [NBP1-28863] - Analysis of human cerebra (left) and breast carcinoma tissue (right), showing nuclear location with DAB staining using NCOR1 mouse mAb.](http://images.novusbio.com/fullsize/NCOR1-Antibody-7A7A9-Immunohistochemistry-Paraffin-NBP1-28863-img0005.jpg "Immunohistochemistry-Paraffin: NCOR1 Antibody (7A7A9) [NBP1-28863] - Analysis of human cerebra (left) and breast carcinoma tissue (right), showing nuclear location with DAB staining using NCOR1 mouse mAb.")
![Immunocytochemistry/ Immunofluorescence: NCOR1 Antibody (7A7A9) - BSA Free [NBP1-28863] - Expressive analysis of LAMP-2A & N-CoR in clinical samples. a mRNA levels of LAMP-2A & N-CoR were measured by qRT-PCR. b Protein levels of LAMP-2A & N-CoR were measured by western blot. LAMP-2A mRNA & protein levels were significantly increased in GBM center (n = 8) in comparison with peri-tumor edema zone (PTEZ, n = 8) (p < 0.0001), while increasing trend was observed as compared with low grade glioma (LGG, n = 8). The protein level of N-CoR, but not mRNA level was significantly decreased in GBM center as compared with PTEZ (p < 0.0001). Linear regression analysis incorporating data from LGG, GBM center & PTEZ revealed moderate negative correlation between protein expression of LAMP-2A & that of N-CoR (r = − 0.6001, p = 0.0019). c Immunohistochemistry (IHC) analysis of LAMP-2A & N-CoR (brown signal) in glioma clinical samples. Nucleus (blue signal) was stained with hematoxylin; D. immunofluorescence (IF) analysis of LAMP-2A (green signal) & N-CoR (red signal) in glioma clinical samples. DNA (blue signal) was stained with DAPI. Both IHC & IF studies displayed upregulation of LAMP-2A & downregulation of N-CoR in GBM centers. The data are mean ± SEM from 8 tissue specimens as a group. mRNA or protein levels are expressed relative to LGG set as 1. Significant changes are set as p < 0.05 & represented by asterisk (One-Way ANOVA; Bonferroni's test) Image collected & cropped by CiteAb from the following publication (//pubmed.ncbi.nlm.nih.gov/33761934), licensed under a CC-BY license. Not internally tested by Novus Biologicals.](http://images.novusbio.com/fullsize/nbp1-28863_mouse-monoclonal-ncor1-antibody-7a7a9-3102024161899.jpg "Immunocytochemistry/ Immunofluorescence: NCOR1 Antibody (7A7A9) - BSA Free [NBP1-28863] - Expressive analysis of LAMP-2A & N-CoR in clinical samples. a mRNA levels of LAMP-2A & N-CoR were measured by qRT-PCR. b Protein levels of LAMP-2A & N-CoR were measured by western blot. LAMP-2A mRNA & protein levels were significantly increased in GBM center (n = 8) in comparison with peri-tumor edema zone (PTEZ, n = 8) (p < 0.0001), while increasing trend was observed as compared with low grade glioma (LGG, n = 8). The protein level of N-CoR, but not mRNA level was significantly decreased in GBM center as compared with PTEZ (p < 0.0001). Linear regression analysis incorporating data from LGG, GBM center & PTEZ revealed moderate negative correlation between protein expression of LAMP-2A & that of N-CoR (r = − 0.6001, p = 0.0019). c Immunohistochemistry (IHC) analysis of LAMP-2A & N-CoR (brown signal) in glioma clinical samples. Nucleus (blue signal) was stained with hematoxylin; D. immunofluorescence (IF) analysis of LAMP-2A (green signal) & N-CoR (red signal) in glioma clinical samples. DNA (blue signal) was stained with DAPI. Both IHC & IF studies displayed upregulation of LAMP-2A & downregulation of N-CoR in GBM centers. The data are mean ± SEM from 8 tissue specimens as a group. mRNA or protein levels are expressed relative to LGG set as 1. Significant changes are set as p < 0.05 & represented by asterisk (One-Way ANOVA; Bonferroni's test) Image collected & cropped by CiteAb from the following publication (//pubmed.ncbi.nlm.nih.gov/33761934), licensed under a CC-BY license. Not internally tested by Novus Biologicals.")
![Immunocytochemistry/ Immunofluorescence: NCOR1 Antibody (7A7A9) - BSA Free [NBP1-28863] - Expressive analysis of LAMP-2A & N-CoR in clinical samples. a mRNA levels of LAMP-2A & N-CoR were measured by qRT-PCR. b Protein levels of LAMP-2A & N-CoR were measured by western blot. LAMP-2A mRNA & protein levels were significantly increased in GBM center (n = 8) in comparison with peri-tumor edema zone (PTEZ, n = 8) (p < 0.0001), while increasing trend was observed as compared with low grade glioma (LGG, n = 8). The protein level of N-CoR, but not mRNA level was significantly decreased in GBM center as compared with PTEZ (p < 0.0001). Linear regression analysis incorporating data from LGG, GBM center & PTEZ revealed moderate negative correlation between protein expression of LAMP-2A & that of N-CoR (r = − 0.6001, p = 0.0019). c Immunohistochemistry (IHC) analysis of LAMP-2A & N-CoR (brown signal) in glioma clinical samples. Nucleus (blue signal) was stained with hematoxylin; D. immunofluorescence (IF) analysis of LAMP-2A (green signal) & N-CoR (red signal) in glioma clinical samples. DNA (blue signal) was stained with DAPI. Both IHC & IF studies displayed upregulation of LAMP-2A & downregulation of N-CoR in GBM centers. The data are mean ± SEM from 8 tissue specimens as a group. mRNA or protein levels are expressed relative to LGG set as 1. Significant changes are set as p < 0.05 & represented by asterisk (One-Way ANOVA; Bonferroni's test) Image collected & cropped by CiteAb from the following publication (//pubmed.ncbi.nlm.nih.gov/33761934), licensed under a CC-BY license. Not internally tested by Novus Biologicals.](http://images.novusbio.com/fullsize/nbp1-28863_mouse-monoclonal-ncor1-antibody-7a7a9-31020241618918.jpg "Immunocytochemistry/ Immunofluorescence: NCOR1 Antibody (7A7A9) - BSA Free [NBP1-28863] - Expressive analysis of LAMP-2A & N-CoR in clinical samples. a mRNA levels of LAMP-2A & N-CoR were measured by qRT-PCR. b Protein levels of LAMP-2A & N-CoR were measured by western blot. LAMP-2A mRNA & protein levels were significantly increased in GBM center (n = 8) in comparison with peri-tumor edema zone (PTEZ, n = 8) (p < 0.0001), while increasing trend was observed as compared with low grade glioma (LGG, n = 8). The protein level of N-CoR, but not mRNA level was significantly decreased in GBM center as compared with PTEZ (p < 0.0001). Linear regression analysis incorporating data from LGG, GBM center & PTEZ revealed moderate negative correlation between protein expression of LAMP-2A & that of N-CoR (r = − 0.6001, p = 0.0019). c Immunohistochemistry (IHC) analysis of LAMP-2A & N-CoR (brown signal) in glioma clinical samples. Nucleus (blue signal) was stained with hematoxylin; D. immunofluorescence (IF) analysis of LAMP-2A (green signal) & N-CoR (red signal) in glioma clinical samples. DNA (blue signal) was stained with DAPI. Both IHC & IF studies displayed upregulation of LAMP-2A & downregulation of N-CoR in GBM centers. The data are mean ± SEM from 8 tissue specimens as a group. mRNA or protein levels are expressed relative to LGG set as 1. Significant changes are set as p < 0.05 & represented by asterisk (One-Way ANOVA; Bonferroni's test) Image collected & cropped by CiteAb from the following publication (//pubmed.ncbi.nlm.nih.gov/33761934), licensed under a CC-BY license. Not internally tested by Novus Biologicals.")
![Western Blot CBP/KAT3A Antibody (257003) [Unconjugated]](https://images.novusbio.com/images2/CBP_MAB2676_Western_Blot_6043.jpg)
![Immunocytochemistry CBP/KAT3A Antibody (257003) [Unconjugated]](https://images.novusbio.com/images2/mab2676_human-mouse-rat-cbp-mab-clone-257003-immunocytochemistry-101220208237.jpg)
![Western Blot Androgen R/NR3C4 [p Ser213, p Ser210] Antibody (156C135.2) - BSA Free](https://images.novusbio.com/images/Androgen-R-NR3C4-p-Ser213-p-Ser210-Antibody-156C135-2-Western-Blot-NB100-56603-img0004.jpg)
![SDS-Page: Mouse IgG1 Isotype Control (MG1) [NBP1-97005] - Lane 1: , Non-reduced. M: Opal Pre-stained Ladder. Lane 2: , Reduced. Load: 1.0 ug per lane. Predicted/Observed: 120 kDa Non-reduced, 55 and 25 Reduced.](https://images.novusbio.com/images/Mouse-IgG1-Isotype-Control-MG1-SDS-Page-NBP1-97005-img0002.jpg "SDS-Page: Mouse IgG1 Isotype Control (MG1) [NBP1-97005] - Lane 1: , Non-reduced. M: Opal Pre-stained Ladder. Lane 2: , Reduced. Load: 1.0 ug per lane. Predicted/Observed: 120 kDa Non-reduced, 55 and 25 Reduced.")